“…GPR68 is an understudied orphan G-protein coupled receptor (oGPCR). First cloned from an ovarian cancer cell line for ovarian cancer G-protein-couple receptor 1 (therefore also known as OGR1 in the literature), it is widely expressed in most tissues and cells − and functions as a proton-sensing receptor. , Together with two other orphan receptors, GPR4 and GPR65 (previously known as TDAG8), they form a subfamily of proton-sensing GPCRs. − In responding to acidic extracellular conditions, GPR68 couples to multiple downstream signaling pathways via different families of G-proteins in different cells, including G q/11 , G s , G i/o , and G 12/13 , ,,, and has been implicated in a range of biological processes and pathological conditions, including pH homeostasis, insulin secretion, bone metabolism, learning and memory, blood flow and mechanosensing, inflammation, tumor metastasis and growth, and hematopoiesis. ,− As one of the understudied GPCR targets of the NIH funded Illuminating the Druggable Genome (IDG) program (), GPR68 has been receiving increasing attention in recent years and represents a potential therapeutic target for drug design and development.…”